Adam Marks
About Me
Adam Marks is an MD/PhD candidate at the Icahn School of Medicine at Mount Sinai, where his PhD work in the Brown Lab focuses on genetics & gene therapy, immunology, and drug delivery. His research centers on developing tissue- and cell-targeted delivery platforms for RNA-based therapies to better understand the interface between immunization and immune tolerance. He graduated from McGill University in 2016 with a Bachelor of Science in Biochemistry and has previously conducted research at The Rockefeller University and University College London.
Language
English
Position
GRADUATE STUDENT | Graduate Students
Research Topics
Cancer, Drug Resistance, Gene Therapy, Gene editing, Genetics, Immunology, Inflammation, RNA, RNA Transport & Localization, Vaccine Development
Multi-Disciplinary Training Areas
Genetics and Genomic Sciences [GGS], Immunology [IMM]
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. MARKS has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.